Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Release info for hum0200

  • hum0200-v7

    2026-02-04
    Datasets added in this release
    Release note
    - 3 tumor sections from an Invasive Ductal Carcinoma (IDC) patient were used for Xenium In Situ Gene Expression Assay. Csv, h5, html, json, mtx, tiff, parquet, tsv, xenium, and zarr files are provided.
    - DNAs/RNAs extracted from non-tumor tissues of an Invasive Ductal Carcinoma (IDC) patient were used for the whole genome sequencing, RNA-seq and EM-seq analyses. Fastq files are provided.

  • hum0200-v6

    2024-11-25
    Datasets added in this release
    Release note
    DNAs/RNAs extracted from tumor and non-tumor tissues of an Invasive Ductal Carcinoma (IDC) patient were used for the whole genome sequencing, RNA-seq, EM-seq and t-nanoEM analyses. Fastq files are provided.

  • hum0200-v5

    2022-08-29
    Datasets added in this release
    Release note
    Semibulks (cell clumps), prepared from the tumor tissues of Ductal Carcinoma In Situ (DCIS) or Invasive Ductal Carcinoma (IDC), were used for semibulk RNA-seq. Single cells, prepared from the tumor or normal tissues of DCIS and IDC, were used for scRNA-seq. Fastq files are provided.

  • hum0200-v4

    2022-03-02
    Datasets added in this release
    Release note
    RNAs extracted from tumor tissues of an Invasive Ductal Carcinoma (IDC) patient were used for Visium Spatial Gene Expression Assay. Fastq files, tif files (histological image for Visium Spatial Gene Expression Assay) and a tsv file are provided.

  • hum0200-v3

    2021-10-01
    Datasets added in this release
    Release note
    DNAs extracted from tumor tissues of 2 Invasive Ductal Carcinoma (IDC) patients and 72 Ductal Carcinoma In Situ (DCIS) patients were used for the target capture sequencing and RNAs extracted from tumor tissues of 2 IDC patients and a DCIS patient were used for Visium Spatial Gene Expression Assay. Fastq files and tif files (histological image for Visium Spatial Gene Expression Assay) are provided.

  • hum0200-v2

    2021-05-07
    Datasets added in this release
    Release note
    DNAs extracted from tumor and non-tumor tissues of 2 Ductal Carcinoma In Situ (DCIS) patients were used for the whole genome sequencing and DNAs extracted from tumor and non-tumor tissues of 2 Invasive Ductal Carcinoma (IDC) patients and a DCIS patient were used for Methylation analysis. Fastq files and tsv files (CpG methylation calls for 2 patients) are provided.

  • hum0200-v1

    2021-03-29
    Datasets added in this release
    Release note
    DNAs extracted from tumor and non-tumor tissues of 25 Ductal Carcinoma In Situ (DCIS) patients were used for the whole exome sequencing and single-cells from tumor tissues of 2 DCIS patients were used for single-cell CNV analysis. Fastq files are provided.